According to AIIMS director Dr Guleria, results of the Covaxin trials on children can be expected in September.
Trials of Bharat Biotech's Covaxin on children are currently underway, with the second dose of the Covid-19 vaccine likely to be administered to children aged 2-6 years next week.
Also Read Bharat Biotech terminates MoU with Brazilian partners amid corruption allegations
The second dose of Covaxin has already been given to children between the ages of 6-12 years at the Delhi AIIMS.
Trials of Covaxin on children have been going on ever since the DCGI granted permission to Bharat Biotech in May.
With the fear of a third Covid-19 wave looming large, some experts have raised concerns that children will be infected in the next wave.